Keyword: Clementia Pharmaceuticals
The transaction will see Ipsen hand over $1 billion upfront to acquire the retinoic acid receptor gamma agonist ahead of a filing for FDA approval.
2017 was "good, but not great" for biotech IPOs, yet insider buying was still high at 34%.
Check out Friday's dose of biotech's news of note.
Clementia Pharmaceuticals has filed to raise $115 million in an IPO.